CA3044262A1 - Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci - Google Patents
Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ciInfo
- Publication number
- CA3044262A1 CA3044262A1 CA3044262A CA3044262A CA3044262A1 CA 3044262 A1 CA3044262 A1 CA 3044262A1 CA 3044262 A CA3044262 A CA 3044262A CA 3044262 A CA3044262 A CA 3044262A CA 3044262 A1 CA3044262 A1 CA 3044262A1
- Authority
- CA
- Canada
- Prior art keywords
- transcript
- cancer
- mtdna
- mitochondrial
- transcripts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Il est décrit de nouvelles transcriptions de fusion mitochondriale ainsi que les molécules dADNmt mutée parente utiles pour la prévision, le diagnostic et/ou la surveillance du cancer. Il est également décrit des sondes dhybridation complémentaires prévues pour lutilisation dans le cadre de méthodes décrites.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4061608P | 2008-03-28 | 2008-03-28 | |
US61/040,616 | 2008-03-28 | ||
CA2719718A CA2719718C (fr) | 2008-03-28 | 2009-03-27 | Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2719718A Division CA2719718C (fr) | 2008-03-28 | 2009-03-27 | Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci |
Publications (2)
Publication Number | Publication Date |
---|---|
CA3044262A1 true CA3044262A1 (fr) | 2009-10-01 |
CA3044262C CA3044262C (fr) | 2023-02-28 |
Family
ID=41112880
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3044262A Active CA3044262C (fr) | 2008-03-28 | 2009-03-27 | Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci |
CA2719718A Expired - Fee Related CA2719718C (fr) | 2008-03-28 | 2009-03-27 | Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2719718A Expired - Fee Related CA2719718C (fr) | 2008-03-28 | 2009-03-27 | Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci |
Country Status (10)
Country | Link |
---|---|
US (4) | US20110172113A1 (fr) |
EP (1) | EP2274426B1 (fr) |
JP (1) | JP5938690B2 (fr) |
KR (2) | KR101819852B1 (fr) |
CN (3) | CN107011428B (fr) |
AU (1) | AU2009227935B2 (fr) |
CA (2) | CA3044262C (fr) |
NZ (2) | NZ602175A (fr) |
SG (3) | SG192453A1 (fr) |
WO (1) | WO2009117811A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ602175A (en) | 2008-03-28 | 2014-03-28 | Mitomics Inc | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
EP3272871B1 (fr) * | 2009-03-27 | 2020-01-15 | MDNA Life Sciences Inc. | Adn mitochondrial aberrant, transcription de fusion associées, produits de translation et sondes d'hybridation associées |
WO2011106892A1 (fr) * | 2010-03-01 | 2011-09-09 | Mitomics Inc. | Produits de transcription de fusion d'adn-mt associés aux uv et méthodes et utilisations de ceux-ci |
WO2012021512A2 (fr) | 2010-08-10 | 2012-02-16 | Ecole Polytechnique Federale De Lausanne | Agents thérapeutiques se liant aux érythrocytes |
US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
AU2015233084B2 (en) | 2014-02-21 | 2020-12-17 | Anokion Sa | Glycotargeting therapeutics |
US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
CA3029211A1 (fr) * | 2016-06-22 | 2017-12-28 | Degen Zhuo | Procede et kit de detection de produits de transcription de fusion |
US11978535B2 (en) * | 2017-02-01 | 2024-05-07 | The Translational Genomics Research Institute | Methods of detecting somatic and germline variants in impure tumors |
EP3638296A1 (fr) | 2017-06-16 | 2020-04-22 | The University Of Chicago | Compositions et procédés d'induction d'une tolérance immunitaire |
EP3774890A4 (fr) * | 2018-03-26 | 2022-05-04 | The University of Chicago | Procédés et compositions permettant de cibler une lectine de type c de cellules endothéliales sinusoïdales du foie et des ganglions lymphatiques (lsectine) |
CN117384269B (zh) * | 2023-09-21 | 2024-06-18 | 南方医科大学南方医院 | 短肽mfrlp及其在制备动脉重塑相关疾病药物中的应用 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) * | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) * | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) * | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) * | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4277437A (en) * | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) * | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4366241A (en) * | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US5807522A (en) * | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US6605433B1 (en) * | 1998-08-20 | 2003-08-12 | The Johns Hopkins University | Mitochondrial dosimeter |
US6203990B1 (en) * | 1998-11-06 | 2001-03-20 | Mitokor | Method and system for pattern analysis, such as for analyzing oligonucleotide primer extension assay products |
US6933120B2 (en) * | 2000-06-20 | 2005-08-23 | Michael D. Seidman | Method of determining biological/molecular age |
JP2005506057A (ja) * | 2001-06-11 | 2005-03-03 | 1304854 オンタリオ・リミテッド | 健康科学のための診断ツールとしての全ミトコンドリアゲノム配列 |
US20030162174A1 (en) * | 2001-06-11 | 2003-08-28 | Sutherland John W. | Detecting nucleic acid deletion sequences |
US20050026167A1 (en) * | 2001-06-11 | 2005-02-03 | Mark Birch-Machin | Complete mitochondrial genome sequences as a diagnostic tool for the health sciences |
GB2380194B (en) * | 2001-10-01 | 2005-06-22 | Roger Michael Marchbanks | A mitochondrial mutation associated with schizophrenia and increased oxidative stress |
US20060051796A1 (en) * | 2004-09-09 | 2006-03-09 | Inga Boell | Real time PCR with the addition of pyrophosphatase |
EP2339032B1 (fr) * | 2005-04-18 | 2016-12-28 | MDNA Life Sciences Inc. | Mutations mitochondriales et réagencements en tant qu'outil de diagnostic pour la détection de l'exposition au soleil, cancer de la prostate et autres cancers |
US20070134678A1 (en) * | 2005-12-12 | 2007-06-14 | Rees Dianne M | Comparative genome hybridization of organelle genomes |
ES2484044T3 (es) | 2007-09-26 | 2014-08-08 | Mitomics Inc. | Deleción de 3,4 kb en el ADN mitocondrial para uso en la detección de cáncer |
NZ602175A (en) * | 2008-03-28 | 2014-03-28 | Mitomics Inc | Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor |
EP3272871B1 (fr) | 2009-03-27 | 2020-01-15 | MDNA Life Sciences Inc. | Adn mitochondrial aberrant, transcription de fusion associées, produits de translation et sondes d'hybridation associées |
WO2011106892A1 (fr) * | 2010-03-01 | 2011-09-09 | Mitomics Inc. | Produits de transcription de fusion d'adn-mt associés aux uv et méthodes et utilisations de ceux-ci |
-
2009
- 2009-03-27 NZ NZ602175A patent/NZ602175A/en not_active IP Right Cessation
- 2009-03-27 SG SG2013050448A patent/SG192453A1/en unknown
- 2009-03-27 JP JP2011501069A patent/JP5938690B2/ja not_active Expired - Fee Related
- 2009-03-27 CN CN201710183734.1A patent/CN107011428B/zh active Active
- 2009-03-27 NZ NZ588658A patent/NZ588658A/xx not_active IP Right Cessation
- 2009-03-27 CA CA3044262A patent/CA3044262C/fr active Active
- 2009-03-27 US US12/935,181 patent/US20110172113A1/en not_active Abandoned
- 2009-03-27 CN CN200980114773.XA patent/CN102016039B/zh not_active Expired - Fee Related
- 2009-03-27 CA CA2719718A patent/CA2719718C/fr not_active Expired - Fee Related
- 2009-03-27 AU AU2009227935A patent/AU2009227935B2/en not_active Ceased
- 2009-03-27 EP EP09725638.2A patent/EP2274426B1/fr not_active Not-in-force
- 2009-03-27 WO PCT/CA2009/000351 patent/WO2009117811A1/fr active Application Filing
- 2009-03-27 KR KR1020167036800A patent/KR101819852B1/ko active IP Right Grant
- 2009-03-27 KR KR1020107024109A patent/KR101693387B1/ko active IP Right Grant
-
2010
- 2010-03-29 SG SG2011068467A patent/SG174514A1/en unknown
- 2010-03-29 SG SG10201400985RA patent/SG10201400985RA/en unknown
- 2010-03-29 CN CN201080014122.6A patent/CN102388140B/zh not_active Expired - Fee Related
- 2010-03-29 US US13/260,497 patent/US8715960B2/en not_active Expired - Fee Related
-
2015
- 2015-02-20 US US14/627,755 patent/US10266899B2/en active Active
-
2019
- 2019-04-17 US US16/386,381 patent/US20190382846A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20110004860A (ko) | 2011-01-14 |
US20170152567A1 (en) | 2017-06-01 |
CN102388140A (zh) | 2012-03-21 |
SG10201400985RA (en) | 2014-05-29 |
KR101819852B1 (ko) | 2018-02-28 |
WO2009117811A1 (fr) | 2009-10-01 |
EP2274426A1 (fr) | 2011-01-19 |
NZ602175A (en) | 2014-03-28 |
CN102388140B (zh) | 2015-07-08 |
AU2009227935B2 (en) | 2015-07-09 |
CN107011428A (zh) | 2017-08-04 |
NZ588658A (en) | 2012-10-26 |
US20130059299A1 (en) | 2013-03-07 |
US20190382846A1 (en) | 2019-12-19 |
EP2274426A4 (fr) | 2011-11-16 |
SG174514A1 (en) | 2011-10-28 |
US20110172113A1 (en) | 2011-07-14 |
CA3044262C (fr) | 2023-02-28 |
CN102016039A (zh) | 2011-04-13 |
KR101693387B1 (ko) | 2017-01-05 |
CN107011428B (zh) | 2022-02-25 |
JP5938690B2 (ja) | 2016-06-22 |
US10266899B2 (en) | 2019-04-23 |
CA2719718C (fr) | 2019-07-02 |
CA2719718A1 (fr) | 2009-10-01 |
AU2009227935A1 (en) | 2009-10-01 |
SG192453A1 (en) | 2013-08-30 |
JP2011515091A (ja) | 2011-05-19 |
US8715960B2 (en) | 2014-05-06 |
KR20170004033A (ko) | 2017-01-10 |
CN102016039B (zh) | 2017-06-09 |
EP2274426B1 (fr) | 2016-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3044262C (fr) | Adn mitochondrial aberrant, produits de transcription de fusion associes et sondes d'hybridation pour celui-ci | |
KR101074841B1 (ko) | 방광암 특이적 메틸화 마커 유전자를 이용한 방광암 진단용키트 및 칩 | |
US20130065789A1 (en) | Compositions and methods for classifying lung cancer and prognosing lung cancer survival | |
KR101825117B1 (ko) | Pna 기반의 실시간 pcr 클램핑을 이용한 braf 돌연변이 검출 방법 및 키트 | |
AU2010234238B2 (en) | Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor | |
KR101255768B1 (ko) | 자궁경부암 특이적 메틸화 유전자의 CpG 섬을 함유하는 자궁경부암 또는 자궁경부암 진행단계 진단용 바이오마커 | |
KR101064561B1 (ko) | 폐선암 수술 후 초기 재발 예측용 바이오마커 | |
EP1038026B1 (fr) | Analyse diagnostique permettant de determiner la susceptibilite au cancer | |
KR101323101B1 (ko) | 유방암 또는 난소암의 유전성 소인 예측에 유용한 brca2 유전자 돌연변이 | |
CA2756824A1 (fr) | Adn mitochondrial aberrant, transcrits de fusion et produits de traduction associes et sondes d'hybridation complementaires | |
WO2016083466A1 (fr) | Nouveau gène suppresseur de tumeur et utilisations de celui-ci pour le traitement et le diagnostic du cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20190527 |
|
EEER | Examination request |
Effective date: 20190527 |
|
EEER | Examination request |
Effective date: 20190527 |
|
EEER | Examination request |
Effective date: 20190527 |
|
EEER | Examination request |
Effective date: 20190527 |
|
EEER | Examination request |
Effective date: 20190527 |
|
EEER | Examination request |
Effective date: 20190527 |